BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 645278)

  • 1. [Value of suspicious and doubtful cytological findings in gynecologic serial examinations].
    Goldmann C; Herold E; Neuser D; Sielaff E
    Zentralbl Gynakol; 1978; 100(1):17-22. PubMed ID: 645278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of cytological screening for neoplasms in young women].
    Kubista E; Kucera H; Ulm R
    Osterr Z Onkol; 1976; 3(4):103-6. PubMed ID: 1037017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of cytological routine checks (author's transl)].
    Scholz A
    Zentralbl Gynakol; 1979; 101(15):958-61. PubMed ID: 532421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic verification of Group III and III D cytological tests with special reference to follow-up].
    Schlegel H; Kühndel K
    Zentralbl Gynakol; 1983; 105(24):1585-96. PubMed ID: 6666444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clarification of cytologically doubtful findings of the cervix by DNA-single-cell-fluorescence-cytophotometry].
    Hilgarth M
    Fortschr Med; 1976 Sep; 94(27):1485-7. PubMed ID: 786837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
    Liao SY; Stanbridge EJ
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytological and histological parallels in atypical colposcopic findings].
    Raĭcheva I; Lazarova L; Zlatkov V; Maĭnkhard K; Raĭcheva S; Zamfirova K
    Akush Ginekol (Sofiia); 1998; 37(2):23-5. PubMed ID: 9859530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence, causes and follow-up of doubtful smear findings (Papanicolaou group III)].
    Hofmann R; Barten G; Rohde E; Beust M; Hamann H
    Zentralbl Gynakol; 1989; 111(23):1549-54. PubMed ID: 2624007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement].
    Geertsen M; Bais AG; Beerman H; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2430-4. PubMed ID: 14694554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of the use of Pap test in a sample of pregnant women].
    Dindelli M; Parazzini F; Rabaiotti E; Liati P; Ferrari A
    Minerva Ginecol; 1990; 42(7-8):305-8. PubMed ID: 2293073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the maintenance of the accuracy of cytological diagnosis in the mass screening of uterine cervical cancer].
    Takahashi K; Yamane Y; Fukuda S; Kijima S; Moriyama M; Kitao M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):633-7. PubMed ID: 3722946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cervix smears with mild atypia classified as Pap-class IIIA: results of a changed policy].
    Doornewaard H; Woudt JM; Sie-Go DM; Kooijman CD
    Ned Tijdschr Geneeskd; 1991 Sep; 135(36):1642-5. PubMed ID: 1922503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytological finding in the pre- and early stages of cervix carcinoma--a contribution to the evaluation of Papanicolau III].
    Bader G; Büttner HH; Neumann HG; Rhode E; Beust M
    Zentralbl Gynakol; 1977; 99(11):657-60. PubMed ID: 899349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of dubious and positive cervical cytological examinations for neoplasms and correlated histological examinations made 1970-1980 at the Savona Hospital].
    Ballerini D; De Pirro W; Nadin C
    Pathologica; 1981; 73(1027):793-803. PubMed ID: 7043381
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytologic follow-up examination of patients with a suspicious Papanicoaou type 3D smear (author's transl)].
    Rummel HH; Fick R; Heberling D; Schubert D
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):521-6. PubMed ID: 885324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Habbema JD
    Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1586-90. PubMed ID: 12224483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAP smear after radiation therapy for cervical carcinoma.
    Rintala MA; Rantanen VT; Salmi TA; Klemi PJ; Grénman SE
    Anticancer Res; 1997; 17(5B):3747-50. PubMed ID: 9427773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of atypia in conventional Papanicolaou smears and liquid-based cytology: a follow-up study.
    Schledermann D; Ejersbo D; Hoelund B
    Cytopathology; 2004 Jun; 15(3):148-53. PubMed ID: 15165271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.